NCT07222800 2026-04-08
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Phase 3 Recruiting
Clinical Trials
37 trialsNCT03093116 2026-04-03
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07351071 2026-03-17
SECURE
Medtronic - MITG
Phase NA Recruiting
NCT07253298 2025-11-28
BFT in LARS
National Taiwan University Hospital
Phase NA Not yet recruiting
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT07086833 2025-07-25
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
Phase NA Recruiting
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT01550510 2025-05-06
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Phase 1/2 Terminated
NCT06524362 2024-07-29
PERECARE
GEM Hospital & Research Center
Phase NA Not yet recruiting
NCT06435975 2024-05-30
Physical Activity in Rectal Cancer Survivors
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT05880446 2024-05-13
PROCAR-BQ
Jules Bordet Institute
Phase NA Completed
NCT04755920 2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2 Recruiting
NCT00838578 2024-04-26
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
Phase 1/2 Terminated
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT03559543 2024-02-07
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT04644315 2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2 Terminated
NCT04080843 2022-07-13
ALTER-C-002
Zhejiang University
Phase 2 Completed
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT02981524 2021-02-10
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04733794 2021-02-03
Feasibility Bowel Dysfunction Program After Low Anterior Resection
Fox Chase Cancer Center
Phase NA Completed
NCT01397305 2020-09-09
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT02785783 2019-02-04
Erings™
Portsmouth Hospitals NHS Trust
Phase NA Completed
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03072472 2018-09-06
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Phase NA Completed
NCT03280407 2017-09-28
NEOLAR
Zealand University Hospital
Phase 2 Unknown
NCT00101998 2017-08-30
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00241722 2017-08-30
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT00135577 2015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00256932 2015-09-02
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT00259922 2015-09-02
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01269567 2015-07-23
GRECCAR 5
University Hospital, Bordeaux
Phase 3 Completed
NCT01294826 2015-06-08
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Swedish Medical Center
Phase 1 Completed
NCT00808743 2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3 Completed
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown